Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences
23 mai 2013 16h30 HE
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., May 23, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences
09 mai 2013 16h30 HE
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., May 9, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals Reports First Quarter 2013 Financial Results
30 avr. 2013 08h00 HE
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., April 30, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals Announces Date of First Quarter 2013 Financial Results Conference Call and Webcast
09 avr. 2013 16h15 HE
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., April 9, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will...
Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences
25 févr. 2013 16h30 HE
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Feb. 25, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals Reports Fourth Quarter and Year End 2012 Financial Results
15 févr. 2013 08h00 HE
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Feb. 15, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) today reported its financial results for the fourth quarter and year ended December 31, 2012.
For the...
Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investor Conferences
07 févr. 2013 09h00 HE
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Feb. 7, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals Announces Date of Fourth Quarter and Year End 2012 Financial Results Conference Call and Webcast
24 janv. 2013 08h30 HE
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Jan. 24, 2013 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will...
Momenta Pharmaceuticals to Present at the Deutsche Bank 2012 dbAccess BioFEST
27 nov. 2012 16h30 HE
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Nov. 27, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
U.S. Court of Appeals Denied Momenta Pharmaceuticals Petition for Rehearing En Banc in "Safe-Harbor" Case
20 nov. 2012 12h41 HE
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Nov. 20, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...